ArticleBiochemistry and biophysics reports2025
Rapid detection of Senecavirus A using a colloidal gold lateral flow strip.
Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Visual typing detection of bovine leukemia virus with a lateral flow immunoassay based on latex microspheres.Archives of virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Senecavirus A (SVA) could cause vesicular lesions and other symptoms in pigs, which has resulted in substantial economic losses to the swine industry. To establish a rapid detection method for SVA, an immunochromatographic lateral flow strip was constructed. First, the recombinant SVA VP2 protein was purified, and the monoclonal antibodies were prepared. 4B10 was coated onto the test line (T line), and 1E3 was colloidal gold-labeled to assemble the colloidal gold test strip. The constructed LFA strip showed a detection limit of 0.5 ng/mL, and no cross-reactivity with FMDV, PRRSV, CSFV and PCV2. Clinical samples validation showed 90 % concordance with RT-PCR results, indicated the reliability of this method. The developed lateral flow assay (LFA) provided a rapid and simple method for point-of-care testing of SVA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.